Preoperative stop or continue? New antithrombotic and anticoagulants.
Ickx
B E
BE
Hôpital Erasme, ULB, Bruxelles.
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D003374:Coumarins / Q000008:administration & dosage / Q000009:adverse effects; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006629:Hirudins / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011300:Preoperative Care; D058919:Purinergic P2 Receptor Antagonists; D012307:Risk Factors; D013927:Thrombosis / Q000517:prevention & control; D013928:Thromboxane A2 / Q000008:administration & dosage
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D006629:Hirudins; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D058919:Purinergic P2 Receptor Antagonists; D013928:Thromboxane A2; D006493:Heparin; C030123:coumarin